The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
Anthera Pharmaceuticals Inc. (ANTH)

Anthera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that benefit patients with unmet medical needs. Co. has two Phase 3 product candidates: liprotamase (Sollpura™), which is the treatment of patients with Exocrine Pancreatic Insufficiency, which is seen in patients with cystic fibrosis and other conditions; and blisibimod, which targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus, Immunoglobulin A nephropathy, lupus nephritis, and others.

ANTH SEC Filing Email Alerts Service

Company Name:  Anthera Pharmaceuticals Inc.
Sector:  Biotechnology
Number of ETFs Holding ANTH:  11
Total Market Value Held by ETFs:  $767587
Total Market Capitalization:  $28.00M
% of Market Cap. Held by ETFs:  2.74%
February 24, 2017    7:34 AM Eastern

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Buy (3.00 out of 4)
48th percentile
(ranked lower than approx. 52% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Anthera Pharmaceuticals Inc. (ANTH) Page | The Online Investor | | Copyright © 1998 - 2017, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.